CompletedNCT01404208
2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesOCDBehavioralFrom 7 Years to 17 Years
Study directory
Back to overviewMental health studies with practical context.
Compare studies and check their requirements with the research team.
TerminatedNCT01568216
20101299: Study Effect of AMG 747 on Schizophrenia Negative Symptoms
This study was terminated in the United States, in Australia, in Canada, .... It focuses on schizophrenia.
In United StatesSchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
TerminatedNCT01568229
20110165: Study Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)
This study was terminated in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 60 Years
TerminatedNCT00946985
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years
This study was terminated in the United States, in Canada, in Brazil, .... It focuses on schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 35 Years
CompletedNCT00312494
Ziprasidone With Either Lithium or Divalproex for Bipolarity
This study is completed in the United States. It is testing ziprasidone With Either Lithium or Divalproex for Bipolarity.
In United StatesBipolarityDrugFrom 18 Years to 65 Years
CompletedNCT03796936
3MDR to Treat PTSD With mTBI (3MDR)
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesPTSDBehavioralOver 18 Years
CompletedNCT03039192
Intranasal Esketamine for depression
This study is completed in the United States, in Bulgaria, in Estonia, .... It is testing intranasal Esketamine for depression.
In United StatesDepression, SuicidalityDrugFrom 18 Years to 64 Years
CompletedNCT03097133
Intranasal Esketamine for depression
This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.
In United StatesDepression, SuicidalityDrugFrom 18 Years to 64 Years
CompletedNCT00018850
5HT3 Antagonism and Auditory Gating in Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesSchizophreniaBehavioralFrom 18 Years to 55 Years
CompletedNCT01861847
7-Keto DHEA for PTSD
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesPTSDDrugFrom 18 Years to 64 Years
CompletedNCT05486312
7-week Study With CT-155 in People With Schizophrenia
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesSchizophreniaBehavioralFrom 18 Years to 64 Years
CompletedNCT04235686
8 Week Multi-site Study of MYDAYIS® for Depression in bipolarity
This summary needs review. Please check the official study record and contact the research team for details.
In United StatesBipolarity, DepressionDrugFrom 18 Years to 55 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.